From Family Pharma to Global injectables CDMO

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kimberlee Steele, Chief Commercial Officer at ROIS and Javier López-Belmonte, Vice Chairman of the Board at ROVI and CEO at ROIS.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kimberlee and Javier, covering:

Kimberlee’s 12 golden years at Catalent, and the lessons she learned during a period of significant CDMO growth

The family heritage behind ROVI and its journey to becoming a $4bn market cap global pharmaceutical business

How the pandemic created a quantum leap in the company’s reputation and capabilities in sterile injectables

The ambition behind ROIS and its goal to become one of the world’s leading sterile CDMO specialists

The trend towards self administered medicines, and how this is driving demand for prefilled syringes, cartridges and device assembly

Investing in value added capabilities and significant capacity to ensure reliability of supply for clients

Kimberlee Steele is a seasoned executive with over 25 years CDMO experience, currently serving as Chief Commercial Officer for ROIS. In this role, she is responsible for leading the company’s global commercial strategy, including business development, marketing, and strategic partnerships; supporting ROIS’s growth as a prominent global CDMO specializing in sterile injectables.

Prior to joining ROIS, Steele held several senior leadership roles that reflect her deep industry knowledge and operational experience. She most recently served as Managing Director, North America at SHL Medical, a global autoinjector company. Earlier in her career, she spent more than a decade at Catalent, advancing to Vice President of Strategic Partners and contributing to growth initiatives across biologics, injectables, and advanced drug delivery technologies.

She also previously served board roles with SCbio, American Injectables and Softgel Healthcare Ltd. and volunteered with DCAT Alliance for Industry Women Committee.

Mr. López-Belmonte is an experienced pharmaceutical executive with a strong financial background and more than two decades of leadership at ROVI. He currently serves as CEO of ROIS, ROVI’s CDMO business, and as First Vice Chairman of the Board of Directors of ROVI. In these roles, he has played a key part in the company’s long-term growth, including the expansion of its CDMO capabilities in sterile injectables and complex mol